Before lithium became available to treat this potentially devastating illness, bipolar I sufferers experienced repeated ...
Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with ...
HealthDay on MSN9d
Lithium Linked to Risk for Thyroid Dysfunction, CKD in Bipolar DisorderLithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with ...
BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...
Alzamend Neuro, Inc. (NASDAQ:ALZN) announced it had completed the head coil by Tesla Dynamic Coils BV. The development of the ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Lithium was ...
Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...
Live Science on MSN15d
Massive study of 3 million people reveals genetic 'hotspots' linked to bipolar disorderNotably, though, lithium can cause a range of side effects, so scientists are looking for new solutions to treat the disorder. There are some second-generation antipsychotics approved for bipolar that ...
Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback